Elastomeric Infusion Pumps Market Size to Hit Around USD 1374.13 Mn by 2034
The elastomeric infusion pumps market size was exhibited at USD 679.25 million in 2024 and is projected to hit around USD 1374.13 million by 2034, growing at a CAGR of 7.3% during the forecast period 2025 to 2034.
Elastomeric Infusion Pumps Market Key Takeaways:
?????????????? ?????? ???????? ???????????? ????????????: https://www.novaoneadvisor.com/report/sample/9057
U.S. Elastomeric Infusion Pumps Market Size and Growth 2025 to 2034
The U.S. elastomeric infusion pumps market size is evaluated at USD 203.8 million in 2024 and is projected to be worth around USD 412.2 million by 2034, growing at a CAGR of 6.61% from 2025 to 2034.
North America dominated the elastomeric infusion pumps market with the largest revenue share of 40.0% in 2024, and is primarily driven by the increasing prevalence of chronic diseases, rising demand for home healthcare services, and technological advancements. The region has a well-established healthcare infrastructure, and favorable reimbursement policies further contribute to the market expansion. Moreover, the growing geriatric population in North America is boosting the demand for infusion pumps, including elastomeric pumps. in October 2024, the Clinical UM Guideline (CG-DME-09) from Amerigroup addressed the use of elastomeric infusion pumps for continuous local delivery of analgesia during the post-operative period. The guideline stated that this method was considered not medically necessary for post-operative pain control due to insufficient evidence supporting its effectiveness.
U.S. Elastomeric Infusion Pumps Market Trends
The elastomeric infusion pumps market in the U.S. accounted for the largest revenue share in North America in 2024. In the U.S., the adoption of elastomeric infusion pumps is supported by the country's robust healthcare infrastructure, favorable reimbursement policies, and the presence of key market players. The U.S. Food and Drug Administration (FDA) implemented stringent regulations to ensure the safety and efficacy of infusion pumps, which led to the development of innovative products with advanced features. In August 2023, a review article in Therapeutic Advances in Infectious Disease examined the longstanding use of Outpatient Parenteral Antimicrobial Therapy (OPAT) for its cost savings and reduced hospital stays. It highlighted the challenges and opportunities presented by new drug delivery methods, particularly the rise of continuous infusion (CI) of antimicrobials and elastomeric devices.
Europe Elastomeric Infusion Pumps Market Trends
The elastomeric infusion pump market in Europe is experiencing steady growth supported by factors such as a rising geriatric population, increasing prevalence of chronic diseases, and favorable healthcare policies. According to the European Union's (EU) estimates, the EU population was 448.8 million people, with more than one-fifth (21.3%) of the population aged 65 years and older. The region boasts a well-established healthcare system with high adoption rates of advanced medical technologies. Regulatory bodies, including the European Medicines Agency (EMA), ensure strict compliance with quality standards for medical devices, including infusion pumps.In January 2024, a case study from the British Journal of Nursing highlighted advancements in elastomeric pump technology, specifically the Surefuser + elastomeric infusion pump. This device enables intravenous (IV) therapy to be delivered at the bedside, allowing for patient mobility during treatment. It is effective for both home use and in acute healthcare settings, providing reliability and promoting independence for patients.
The UK elastomeric infusion pumps market has been growing, driven by increasing demand for post-operative pain management solutions that minimize opioid use and systemic side effects. These pumps are used primarily in hospital settings for procedures requiring localized analgesia, such as orthopedic, urological, and post-surgical recovery. In August 2023, a review published in Antibiotics examined the feasibility, effectiveness, and safety of using elastomeric infusion pumps (EMPs) for administering intravenous antimicrobials in inpatient settings. The study found strong preferences among both patients and nurses for EMPs, though only one study with six patients was included.
The elastomeric infusion pumps marketin Germany is well-established, driven by a strong healthcare infrastructure and advanced medical technology adoption. The country has a high demand for reliable, efficient drug delivery systems, particularly in hospitals and home care settings. The market benefits from stringent regulatory frameworks, ensuring product quality and safety. In June 2024, the Generics and Biosimilars Initiative published a study evaluating the physicochemical stability of Fluorouracil Accord solutions in three types of elastomeric infusion pumps: Surefuser+ (Nipro), Easypump (B Braun), and Folfusor SV 2.5 mL/h (Baxter). The study showed that Fluorouracil solutions remained stable for 42 days under various storage conditions, including refrigeration and room temperature, supporting the use of elastomeric infusion pumps for extended storage and preparation of Fluorouracil for infusion.
Asia Pacific Elastomeric Infusion Pumps Market Trends
The elastomeric infusion pumps market in Asia Pacific is rapidly expanding, driven by rapidly expanding healthcare infrastructure, increasing disposable income levels, and growing awareness about advanced medical treatments. Manufacturers are also tapping into the expansion of the healthcare market in emerging economies of China and India, where improving access to medical technologies is supporting the adoption of advanced solutions such as smart elastomeric pumps with features including remote monitoring. In May 2024, the National Medical Products Administration (NMPA) of China highlighted the current state of its medical device standards, with a total of 1,974 effective standards as of December 31, 2023. This includes 271 national and 1,703 industry-specific standards. The NMPA's continued efforts aim to enhance medical device safety and industry oversight, improving both regulatory practices and patient access to essential health products.
The China elastomeric infusion pumps market is growing due to expanding healthcare infrastructure, a rising middle class, and an increasing focus on quality healthcare. As chronic diseases like diabetes and cancer become more prevalent, the demand for effective drug delivery systems, including elastomeric infusion pumps, is expected to rise. The Chinese government’s healthcare reforms are increasing access to advanced medical technologies, creating a favorable environment for market growth. In March 2024, a BMC Public Health article highlighted the growing burden of chronic diseases in southern China. The study, based on a survey of 7,430 residents, found that 66.9% reported chronic conditions with low utilization of community health services. Key factors influencing service use included personal characteristics, health status, service accessibility, and knowledge of chronic diseases.
The elastomeric infusion pumps market in Japan is a leader in adopting elastomeric infusion pumps, with the country’s highly advanced healthcare system and aging population, which has led to a rise in demand for chronic disease management and home healthcare solutions. In September 2024, Japan's Ministry of Internal Affairs and Communications reported that approximately 29.3 percent of the population is elderly, marking the highest percentage of seniors in any nation or region with over 100,000 residents. The market benefits from Japan's strict regulatory standards, ensuring high-quality medical devices. Innovation in Japan focuses on precision, safety features, and compact designs that cater to the unique needs of elderly patients.
The India elastomeric infusion pumps market is growing due to the growing prevalence of chronic diseases, increased healthcare awareness, and improved healthcare infrastructure. As a large and diverse market, India presents significant opportunities for elastomeric infusion pumps, especially in hospitals and home care settings. The country is also witnessing a shift toward affordable, high-quality medical devices, with elastomeric pumps being a cost-effective alternative to electronic infusion pumps. For instance, elastomeric infusion pumps can deliver continuous infusions of analgesics, chemotherapy, and cardiology treatments safely and accurately without needing a power source by utilizing pressure generated by an elastomeric balloon.
Latin America Elastomeric Infusion Pumps Market Trends
The elastomeric infusion pumps market in Latin America is anticipated to grow at the fastest CAGR during the forecast period. Brazil is driving the adoption due to improvements in healthcare infrastructure, increasing healthcare access, and rising chronic disease rates. Countries like Argentina and Colombia are witnessing higher demand for advanced drug delivery systems due to expanding healthcare needs. The market is fueled by an increasing focus on cost-effective healthcare solutions, and elastomeric infusion pumps offer a viable option for hospitals and home care settings. In March 2024, a chapter in the ESPE journal from Banco de la República (the Central Bank of Colombia) projected that by 2030, the total costs of chronic non-communicable diseases (NCDs) in Colombia could reach trillions of pesos, depending on the scenario. While prevention measures may reduce these costs, their impact is not expected before 2030.
The Brazil elastomeric infusion pumps market is agrowing healthcare sector due to a large and diverse patient population, rising incidences of chronic diseases, and increased government investment in healthcare. Brazil has a well-developed healthcare system in urban areas, which is expanding access to advanced medical devices like elastomeric infusion pumps. In addition, Brazil's focus on improving the quality and affordability of healthcare drives demand for cost-effective drug delivery solutions. In November 2024, the journal Public Health published a study assessing the burden of non-communicable diseases (NCDs) in Brazil from 1990 to 2021. It found that premature deaths from NCDs increased until 2019 but declined in 2021. While mortality rates and years of life lost decreased, years lived with disabilities increased.
Middle East And Africa Elastomeric Infusion Pumps Market Trends
The elastomeric infusion pumps market in the Middle East and Africais experiencing growing demand for elastomeric infusion pumps, especially in Saudi Arabia and Kuwait, due to improved healthcare infrastructure, increased government spending, and rising healthcare awareness. The region is experiencing a growing demand for advanced medical devices, including elastomeric infusion pumps, driven by the prevalence of chronic diseases, especially diabetes and cancer. In May 2024, a new elastomeric pain pump was introduced, designed for controlled, continuous delivery of medication at rates between 2 to 10 ml/hour. This device minimizes pain after surgery and during childbirth by providing ongoing pain relief without the need for external power sources. It utilizes a flow restrictor to ensure precise dosage, adhering to the principles of fluid dynamics.
The Saudi Arabia elastomeric infusion pumps market is expanding due to the country’s investment in healthcare infrastructure and rising demand for advanced drug delivery systems. The country’s Vision 2030 initiative focuses on improving healthcare services, which is expected to lead to increased adoption of medical technologies like elastomeric infusion pumps. With a rising incidence of chronic diseases and an aging population, Saudi Arabia is seeing a growing need for reliable and cost-effective drug delivery systems in both hospital and home care settings. In December 2024, the General Authority for Statistics (GASTAT) reported that 97.4% of the Saudi population aged 15 and older had good or better health. However, 18.95% of adults were diagnosed with chronic diseases, with diabetes (9.1%) and high blood pressure (7.9%) being the most prevalent.
Elastomeric Infusion Pumps Market By Product Insights
The continuous rate elastomeric infusion pumps segment led the market with the largest revenue share of 59.13% in 2024, as these pumps provide a steady, controlled flow of medications, making them well-suited for treatments that necessitate constant and regulated drug delivery, such as antibiotic therapies and pain management. Their simplicity and operational efficiency made them a preferred choice across various healthcare settings, driving their significant market share. For instance, in April 2024, Baxter International Inc. received clearance from the FDA for its Novum IQ large-volume infusion pump that includes Dose IQ Safety Software. This enhancement integrates the LVP with Baxter’s existing Infusion Platform, which also features a syringe infusion pump with the same software, enabling healthcare providers to use a unified system across various patient care settings.
Elastomeric Infusion Pumps Market By Application Insights
Based on application, the pain management segment led the market with the largest revenue share of 37.44% in 2024. The increasing prevalence of chronic pain conditions globally leads to a growing demand for effective pain management solutions. The rising geriatric population prone to various chronic illnesses requiring pain management contributes significantly to the market growth in this segment. Elastomeric infusion pumps are widely used to manage pain in acute and chronic settings, enabling patients to self-administer medications as needed and providing effective and convenient pain relief. In November 2023, a study evaluated the effectiveness of intercostal cryonerve block (CryoNB) compared to ropivacaine elastomeric infusion pump (EIP) in managing pain for patients undergoing surgical stabilization of rib fractures. Results showed that CryoNB significantly reduced opioid consumption and pain scores and shortened hospital stays without increasing costs or complications. This technique may enhance multimodal pain management in trauma patients.
Elastomeric Infusion Pumps Market By End-use Insights
Based on end use, the hospital segment led the market with the largest revenue share of 44.0% in 2024. This dominance can be attributed to the widespread adoption of these pumps in various hospital settings, such as surgical wards, intensive care units, and oncology departments. Hospitals require reliable and accurate drug delivery solutions to manage diverse patient needs, from post-operative pain management to chemotherapy administration. Elastomeric infusion pumps are well-suited for these applications, as they offer consistent medication delivery, ease of use, and reduced risk of medication errors compared to traditional IV infusion methods. For instance, a study published in the Journal of Pain Research in 2022 found that using elastomeric infusion pumps for post-operative pain management improved patient satisfaction and reduced opioid consumption, highlighting the growing preference for these devices in pain management applications.
The ambulatory surgical centers (ASCs) segment is anticipated to grow at the fastest CAGR during the forecast period. The increasing shift towards outpatient surgical procedures and the growing preference for minimally invasive surgeries drive the adoption of elastomeric pumps in ASCs. These pumps provide a convenient and cost-effective solution for delivering continuous infusions of pain medications and antibiotics to patients following same-day surgeries, enabling faster recovery and reducing hospital burden. In December 2024, Enfermedades Infecciosas y Microbiología Clínic published a study on outpatient antibiotic therapy with portable elastomeric pumps (pEP). From 2020 to mid-2023 at a Rome hospital, 94 of 490 patients treated with pEP showed an 88.3% infection cure rate, with 12.8% experiencing adverse events. The study concludes that pEP is a safe and effective outpatient option for antibiotic therapy, supporting personalized medicine and antibiotic stewardship.
Some of the prominent players in the elastomeric infusion pumps market include:
领英推荐
Elastomeric Infusion Pumps Market Recent Developments
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the elastomeric infusion pumps market
By Product
By Application
By End-use
By Regional
Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/9057
Access our Premium Real Time Data Intelligence Tool, Visit: https://www.statifacts.com/
You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333
About US
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
Connect with Us
Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
IND Address: 707, Nandan Probiz, Baner,?Pune (MH) – 411045, India
USA:?+1 804 441 9344
APAC:?+61 485 981 310 or +91 87933 22019
Europe:?+44 7383 092 044
Email: [email protected]
You can place an order or ask any questions, please feel free to contact at?[email protected] ?| +1 804 441 9344
Nova One Advisor Group Offer Other Reports:
U.S. Telemedicine Market- https://www.biospace.com/press-releases/u-s-telemedicine-market-size-to-hit-usd-160-45-billion-by-2034
Pyrogen Testing Market- https://www.biospace.com/press-releases/pyrogen-testing-market-size-to-hit-usd-3-52-billion-by-2034
DNA Sequencing Market- https://www.biospace.com/press-releases/dna-sequencing-market-size-to-hit-usd-106-20-billion-by-2034
Infection Control Market- https://www.biospace.com/press-releases/infection-control-market-size-to-hit-usd-438-67-billion-by-2034
Cell Analysis Market - https://www.biospace.com/press-releases/cell-analysis-market-size-to-hit-usd-80-14-billion-by-2034
Cell-based Assays Market - https://www.biospace.com/press-releases/cell-based-assays-market-size-to-surpass-usd-41-1-billion-by-2034
Compression Therapy Market - https://www.biospace.com/press-releases/compression-therapy-market-size-to-hit-usd-9-28-billion-by-2034